These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36183863)

  • 1. Can we enhance the clinical efficacy of cognitive and psychological approaches to treat substance use disorders through understanding their neurobiological mechanisms?
    Maddern XJ; Walker LC; Campbell EJ; Arunogiri S; Haber PS; Morley K; Manning V; Millan EZ; McNally GP; Lubman DI; Lawrence AJ
    Neurosci Biobehav Rev; 2022 Nov; 142():104899. PubMed ID: 36183863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological interventions for co-occurring depression and substance use disorders.
    Hides L; Quinn C; Stoyanov S; Kavanagh D; Baker A
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice.
    Carroll KM
    Ann N Y Acad Sci; 2014 Oct; 1327(1):94-111. PubMed ID: 25204847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future pharmacological treatments for substance use disorders.
    Forray A; Sofuoglu M
    Br J Clin Pharmacol; 2014 Feb; 77(2):382-400. PubMed ID: 23039267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis.
    Ray LA; Meredith LR; Kiluk BD; Walthers J; Carroll KM; Magill M
    JAMA Netw Open; 2020 Jun; 3(6):e208279. PubMed ID: 32558914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsomatic treatment of depression.
    Sherrill JT; Kovacs M
    Child Adolesc Psychiatr Clin N Am; 2002 Jul; 11(3):579-93. PubMed ID: 12222084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders.
    Sofuoglu M; DeVito EE; Waters AJ; Carroll KM
    J Dual Diagn; 2016; 12(1):90-106. PubMed ID: 26828702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis.
    De Crescenzo F; Ciabattini M; D'Alò GL; De Giorgi R; Del Giovane C; Cassar C; Janiri L; Clark N; Ostacher MJ; Cipriani A
    PLoS Med; 2018 Dec; 15(12):e1002715. PubMed ID: 30586362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Interventions for Decision-Making in Addiction: a Systematic Review.
    Verdejo-García A; Alcázar-Córcoles MA; Albein-Urios N
    Neuropsychol Rev; 2019 Mar; 29(1):79-92. PubMed ID: 30259388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
    Vocci FJ; Montoya ID
    Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abstinence-Conflict Model: Toward an Optimal Animal Model for Screening Medications Promoting Drug Abstinence.
    Peck JA
    Int Rev Neurobiol; 2016; 126():391-402. PubMed ID: 27055619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Patient-Tailored Evidence-Based Approach for Developing Early Neuropsychological Training Programs in Addiction Settings.
    Rolland B; D'Hondt F; Montègue S; Brion M; Peyron E; D'Aviau de Ternay J; de Timary P; Nourredine M; Maurage P
    Neuropsychol Rev; 2019 Mar; 29(1):103-115. PubMed ID: 30607658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurobiology of successful abstinence.
    Garavan H; Brennan KL; Hester R; Whelan R
    Curr Opin Neurobiol; 2013 Aug; 23(4):668-74. PubMed ID: 23510740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Office-Based Addiction Treatment in Primary Care: Approaches That Work.
    Edelman EJ; Oldfield BJ; Tetrault JM
    Med Clin North Am; 2018 Jul; 102(4):635-652. PubMed ID: 29933820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of N-acetylcysteine in the management of substance use disorders.
    McClure EA; Gipson CD; Malcolm RJ; Kalivas PW; Gray KM
    CNS Drugs; 2014 Feb; 28(2):95-106. PubMed ID: 24442756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive training for substance use disorders: Neuroscientific mechanisms.
    Verdejo-Garcia A
    Neurosci Biobehav Rev; 2016 Sep; 68():270-281. PubMed ID: 27236041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving translation of animal models of addiction and relapse by reverse translation.
    Venniro M; Banks ML; Heilig M; Epstein DH; Shaham Y
    Nat Rev Neurosci; 2020 Nov; 21(11):625-643. PubMed ID: 33024318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiology of addiction. Toward the development of new therapies.
    Koob GF
    Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition and addiction
.
    Verdejo-Garcia A; Garcia-Fernandez G; Dom G
    Dialogues Clin Neurosci; 2019 Sep; 21(3):281-290. PubMed ID: 31749652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.